Equity Selloff Hits Recent IPOs
Recent IPOs have not been exempt from the steep selloff in the major indices. As of midday Friday, the Renaissance IPO Index was down 5...read more
Biotech companies lead a weak week in IPOs. So far this year, 127 companies have come public, and the average first-day pop has been about 16%. In the past two weeks, 8 of...read more
Intec Pharma, which is developing an improved delivery method of carbidopa/levodopa for Parkinson's disease, raised $30 million by offering 5 million shares at $6. In early trading on the Nasdaq (symbol NTEC), the stock was trading slightly below $6, down 3-5%...read more
US IPO Weekly Recap: One IPO and one bad week in the markets
Equity Selloff Hits Recent IPOs Recent IPOs have not been exempt from the steep selloff in the major indices. As of midday Friday, the Renaissance IPO Index was down 5...read more
US IPO Weekly Recap: A bad week besides biotech
Biotech companies lead a weak week in IPOs. So far this year, 127 companies have come public, and the average first-day pop has been about 16%. In the past two weeks, 8 of...read more
Parkinson's disease biotech Intec Pharma prices IPO at $6
Intec Pharma, which is developing an improved delivery method of carbidopa/levodopa for Parkinson's disease, raised $30 million by offering 5 million shares at $6. In early trading on the Nasdaq (symbol NTEC), the stock was trading slightly below $6, down 3-5%...read more
Week ahead: 10 IPOs set to price during the week of August 3
August 2015 kicks off with ten IPOs on the calendar for this week - more IPOs than all of August 2014 - after a ...read more